(Q46368746)

21 December 2017

title

Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat. (English)

1 reference

21 December 2017

1 reference

Guy A Higgins

1

1 reference

21 December 2017

Theresa M Ballard

2

1 reference

21 December 2017

Michel Enderlin

3

1 reference

21 December 2017

Marie Haman

4

1 reference

21 December 2017

John A Kemp

5

1 reference

21 December 2017

publication date

10 March 2005

1 reference

21 December 2017

published in

Psychopharmacology

1 reference

21 December 2017

volume

179

1 reference

21 December 2017

issue

1

1 reference

21 December 2017

page(s)

85-98

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-005-2203-9

exact match

0 references

cites work

N-methyl-D-aspartic acid receptor structure and function

1 reference

12 December 2020

The effect of (+/-)-CP-101,606, an NMDA receptor NR2B subunit selective antagonist, in the Morris watermaze

1 reference

12 December 2020

Clinical experience with excitatory amino acid antagonist drugs

1 reference

12 December 2020

Effects of NMDA receptor antagonists on passive avoidance learning and retrieval in rats and mice

1 reference

12 December 2020

Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats

1 reference

12 December 2020

Nicotine enhances sustained attention in the rat under specific task conditions

1 reference

12 December 2020

Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibition

1 reference

12 December 2020

Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task.

1 reference

12 December 2020

Decline in visual attention and spatial memory in aged rats.

1 reference

12 December 2020

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

1 reference

12 December 2020

The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry

1 reference

12 December 2020

NMDA receptor pathways as drug targets

1 reference

12 December 2020

Ifenprodil and SL 82.0715 are antagonists at the polyamine site of the N-methyl-D-aspartate (NMDA) receptor

1 reference

12 December 2020

Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal.

1 reference

12 December 2020

Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition

1 reference

12 December 2020

Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization

1 reference

12 December 2020

The messenger RNAs for the N-methyl-D-aspartate receptor subunits show region-specific expression of different subunit composition in the human brain

1 reference

12 December 2020

Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies

1 reference

12 December 2020

An NR2B point mutation affecting haloperidol and CP101,606 sensitivity of single recombinant N-methyl-D-aspartate receptors

1 reference

12 December 2020

Dissociation between cognitive and motor/motivational deficits in the delayed matching to position test: effects of scopolamine, 8-OH-DPAT and EAA antagonists.

1 reference

12 December 2020

Modulation of 45Ca2+ influx into cells stably expressing recombinant human NMDA receptors by ligands acting at distinct recognition sites

1 reference

12 December 2020

Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist

1 reference

12 December 2020

The effect of dizocilpine (MK-801) on spatial and visual discrimination tasks in the rat.

1 reference

12 December 2020

Studies on the subtype selectivity of CP-101,606: evidence for two classes of NR2B-selective NMDA receptor antagonists

1 reference

12 December 2020

Antagonists selective for NMDA receptors containing the NR2B subunit.

1 reference

12 December 2020

Developmental and regional expression in the rat brain and functional properties of four NMDA receptors

1 reference

12 December 2020

5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition

1 reference

12 December 2020

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

1 reference

12 December 2020

(1S,2S)-1-(4-Hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: A Potent New Neuroprotectant Which Blocks N-Methyl-D-Aspartate Responses

1 reference

12 December 2020

NMDA receptor antagonists can enhance or impair learning performance in animals.

1 reference

12 December 2020

Reversal of a vigilance decrement in the aged rat by subtype-selective nicotinic ligands

1 reference

12 December 2020

NMDA antagonists disrupt timing behaviour in rats

1 reference

12 December 2020

Studies of NMDA receptor function and stoichiometry with truncated and tandem subunits.

1 reference

12 December 2020

The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task.

1 reference

12 December 2020

The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.

1 reference

12 December 2020

CP-101,606, a potent neuroprotectant selective for forebrain neurons.

1 reference

12 December 2020

Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

1 reference

12 December 2020

Separation of .alpha.1-adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds

1 reference

12 December 2020

The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism

1 reference

12 December 2020

Comparison of various N-methyl-D-aspartate receptor antagonists in a model of short-term memory and on overt behaviour.

1 reference

12 December 2020

Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit

1 reference

12 December 2020

Contrasting effects of the competitive NMDA antagonist CPP and the non-competitive NMDA antagonist MK 801 on performance of an operant delayed matching to position task in rats.

1 reference

12 December 2020

Age-associated impairments in a test of attention: evidence for involvement of cholinergic systems.

1 reference

12 December 2020

Antiparkinsonian actions of CP-101,606, an antagonist of NR2B subunit-containing N-methyl-d-aspartate receptors.

1 reference

12 December 2020

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

1 reference

12 December 2020

Assessing a vigilance decrement in aged rats: effects of pre-feeding, task manipulation, and psychostimulants

1 reference

12 December 2020

The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex

1 reference

12 December 2020

Identification of amino acid residues of the NR2A subunit that control glutamate potency in recombinant NR1/NR2A NMDA receptors

1 reference

12 December 2020

Memantine in moderate-to-severe Alzheimer's disease

1 reference

12 December 2020

Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.

1 reference

12 December 2020

Effects of the novel NMDA antagonists CP-98,113, CP-101,581 and CP-101,606 on cognitive function and regional cerebral edema following experimental brain injury in the rat.

1 reference

12 December 2020

Memantine hydrochloride.

1 reference

12 December 2020

In vitro binding properties in rat brain of [3H]Ro 25-6981, a potent and selective antagonist of NMDA receptors containing NR2B subunits.

1 reference

12 December 2020

Effects of the NMDA antagonists CPP and MK-801 on delayed conditional discrimination.

1 reference

12 December 2020

Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn.

1 reference

12 December 2020

NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins

1 reference

12 December 2020

Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies

1 reference

12 December 2020

Effects of NMDA receptor antagonists and sigma ligands on the acquisition of conditioned fear in mice

1 reference

12 December 2020

Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit

1 reference

12 December 2020

Local glutamate receptor antagonism in the rat prefrontal cortex disrupts response inhibition in a visuospatial attentional task

1 reference

12 December 2020

Pharmacological characterization of interactions of RO 25-6981 with the NR2B (epsilon2) subunit

1 reference

12 December 2020

Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice

1 reference

12 December 2020

Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms.

1 reference

12 December 2020

Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens.

1 reference

12 December 2020

Increased thresholds for long-term potentiation and contextual learning in mice lacking the NMDA-type glutamate receptor epsilon1 subunit

1 reference

12 December 2020

Distinct spatio-temporal distributions of the NMDA receptor channel subunit mRNAs in the brain.

1 reference

12 December 2020

Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit

1 reference

12 December 2020

Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro.

1 reference

12 December 2020

Increased attention to spatial context increases both place field stability and spatial memory.

1 reference

12 December 2020

Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity

1 reference

12 December 2020

Hyperactivity, hyper-reactivity, and sensorimotor deficits induced by low doses of the N-methyl-D-aspartate non-competitive channel blocker MK801

1 reference

12 December 2020

10.1007/S00213-005-2203-9

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017